Ligand validation:3VSA

MPD: (4S)-2-METHYL-2,4-PENTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VSA_MPD_A_402	78%	65%	0.126	0.968	0.64	0.69	-	-	0	0	100%	1
6L0P_MPD_A_402	85%	70%	0.091	0.955	0.37	0.76	-	-	4	0	100%	1
3VSD_MPD_A_403	80%	33%	0.109	0.958	0.79	1.84	-	1	1	0	100%	1
3VSC_MPD_A_403	78%	61%	0.116	0.959	0.73	0.77	-	-	0	0	100%	1
5B36_MPD_A_403	64%	60%	0.15	0.949	0.71	0.83	-	-	0	0	100%	1
6L0R_MPD_C_402	61%	83%	0.125	0.913	0.28	0.5	-	-	0	0	100%	1
9D77_MPD_A_505	100%	87%	0.032	0.998	0.16	0.52	-	-	1	0	100%	1
9H8Q_MPD_B_602	100%	82%	0.039	0.988	0.35	0.44	-	-	3	0	100%	1
7Z6B_MPD_B_307	99%	74%	0.057	0.986	0.42	0.59	-	-	0	0	100%	1
7ZOB_MPD_F_202	99%	72%	0.056	0.983	0.44	0.65	-	-	0	0	100%	1
4H15_MPD_B_313	97%	89%	0.061	0.974	0.33	0.31	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.